The effect of metformin versus placebo, including three insulin-analogue regimens with variating postprandial glucose regulation, on CIMT in T2DM patients - A randomized, multicenter trial.
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary) ; Metformin (Primary)
- Indications Diabetic angiopathies; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms CIMT
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes
- 25 Sep 2013 Status changed from active, no longer recruiting to completed.
- 25 Sep 2013 Primary endpoint 'Intima-media-thickness' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History